Mersin University
mersin.edu.trTotal trials
156
Active
40
Phase 3
0
Total enrollment
11,707
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| CHX disinfection | — | — | — | — | — | 1 | |
| Genicular blocks | — | — | — | — | — | 1 | |
| Patient Control Analgesia (PCA) Morphine group | — | — | — | — | — | 1 | |
| Paracetamol (acetaminophen) + Diclofenac Sodium | — | — | — | — | — | 1 |
Next readouts
- 2025-08-29
- 2026-08-15
Top conditions
- Anxiety16
- Pain9
- Quality of Life5
- Hemodynamic Instability5
- Sleep Quality4
- Fatigue4
- Interventional3
- Constipation3
Frequently asked questions about Mersin University
- How many clinical trials does Mersin University have on ClinicalTrials.gov?
- Mersin University is listed as the lead sponsor on 156 clinical trials in ClinicalTrials.gov, 40 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Mersin University's trials are in Phase 3?
- 0 of Mersin University's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Mersin University focus on?
- Mersin University's most-studied conditions on ClinicalTrials.gov are Anxiety, Pain, Quality of Life, Hemodynamic Instability, Sleep Quality.
- When are Mersin University's next clinical trial readouts?
- Mersin University has 2 upcoming primary-completion readouts tracked here; the soonest is “Microbiome Changes After Laser and Chlorhexidine Disinfection in Caries Removal”, expected around 2025-08-29.